User ID
  Password
  Language
  Protocol
 
  
  
About
View Full Text
For Contributors
submit paper
 
 
 
Abstract - Case Report

J Cerebrovasc Endovasc Neurosurg. 2024 26(1): 58-64
¨Ï The Journal of Cerebrovascular and Endovascular Neurosurgery
      
 
Flow diverter stenting for intracranial aneurysms in the pediatric population: Two case reports and literature review
Akram M Eraky1, Christina Feller1, Hatem Tolba2, Mokshal Porwal1, Raphael H. Sacho3, Hirad Hedayat1
1Department of Neurosurgery, Medical College of Wisconsin, WI, USA 2Department of Neurology, Medical College of Wisconsin, Wauwatosa, WI, USA 3Department of Neurosurgery, Northwell Health, New York, USA

The Pipeline Embolization Device (PED) is a flow-diverting intraluminal device that is approved for use in adults 18 years or older with internal carotid artery aneurysms. However, it can also be used off-label in pediatric patients with aneurysms that cannot be resolved with traditional endovascular treatments. Herein, we present two cases of flow diversion in the pediatric population with complete obliteration of the aneurysm and excellent outcomes. Flow diversion has been shown to be a safe endovascular option in treating complex aneurysms in children. Larger-sized, multicenter trials are encouraged to compare outcomes between flow diversion and other aneurysm treatment options given the rarity of pediatric aneurysms.
 
Key words : Pediatrics, Flow diversion, Intracranial aneurysms, Neurosurgery, Pipeline Embolization Device
 
 
    
 
 
 

Editorial Office Contact Information
The Journal of Cerebrovascular and Endovascular Neurosurgery (JCEN), Department of Neurosurgery, Wonkwang University
School of Medicine and Hospital, 895, Muwang-ro, Iksan-si, Jeollabuk-do 54538, Korea.
Tel. 82-02-2279-9560, Fax. 82-02-2279-9561, E-mail: editor.jcen@the-jcen.org, Dae-Won Kim
 
This site is available under Creative Commons Attribution-NonCommercial-ShareAlike 4.0 South Korea License (CC BY-NC-SA 4.0);
and the PDF can be downloaded freely. By using this site, you agree to the Terms of Use and Privacy Policy.